NEETPGAI
BlogComparePricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Subjects
  • Previous Year Questions
  • Compare
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Help Center

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Orthopedics/Osteoporosis
    Osteoporosis
    hard
    bone Orthopedics

    A 72-year-old man from Mumbai with a 10-year history of chronic kidney disease (eGFR 35 mL/min/1.73 m²) presents with bone pain and muscle weakness. Laboratory investigations show: serum calcium 7.8 mg/dL (corrected), phosphate 5.2 mg/dL, alkaline phosphatase 120 U/L, and PTH 380 pg/mL (normal 15–65). DEXA scan shows T-score of −1.8 at the lumbar spine. Plain radiographs reveal a 'rugger jersey spine' appearance. Which of the following best explains the paradoxical finding of low bone density with high bone turnover in this patient?

    A. Hypogonadism-induced bone loss with secondary hyperparathyroidism
    B. Aluminum toxicity causing adynamic bone disease
    C. Secondary hyperparathyroidism with increased osteoclast activity and poor mineralization due to phosphate retention and uremia
    D. Primary osteoporosis with superimposed vitamin D deficiency

    Explanation

    ## Clinical Diagnosis: Renal Osteodystrophy (Secondary Hyperparathyroidism) **Key Point:** This patient has **secondary hyperparathyroidism** due to chronic kidney disease (CKD stage 3b), manifesting as high bone turnover with paradoxical low bone density — a hallmark of renal osteodystrophy. ## Pathophysiology of Secondary Hyperparathyroidism in CKD ```mermaid flowchart TD A[Declining GFR < 45 mL/min]:::outcome --> B[Phosphate retention]:::outcome B --> C[↑ FGF23 and ↑ PTH]:::outcome C --> D[Hyperphosphatemia]:::outcome D --> E[↓ Serum calcium]:::outcome E --> F[↑ PTH secretion]:::outcome F --> G[Increased osteoclast activity]:::action G --> H[High bone turnover]:::outcome B --> I[↓ 1,25-dihydroxyvitamin D production]:::outcome I --> J[Impaired mineralization]:::outcome J --> K[Poor bone quality despite high turnover]:::outcome G --> K K --> L[Paradoxical low BMD + high PTH]:::urgent ``` ## Laboratory Interpretation | Parameter | Finding | Significance | |-----------|---------|---------------| | eGFR 35 mL/min | Stage 3b CKD | Triggers phosphate retention and FGF23 elevation | | Calcium 7.8 mg/dL | Low | Stimulates PTH secretion | | Phosphate 5.2 mg/dL | High | Suppresses 1,25-dihydroxyvitamin D; drives secondary hyperparathyroidism | | PTH 380 pg/mL | Markedly elevated | Indicates secondary hyperparathyroidism | | ALP 120 U/L | Elevated | Reflects increased bone turnover | | T-score −1.8 | Low-normal to osteopenic | Paradoxically low despite high bone turnover | **High-Yield:** **Rugger jersey spine** (alternating bands of sclerosis and lucency in vertebral bodies) is pathognomonic for secondary hyperparathyroidism in CKD [cite:Robbins 10e Ch 26]. ## Why High Turnover + Low Density? 1. **Increased osteoclast activity** → rapid bone resorption 2. **Impaired mineralization** → defective osteoid formation due to: - Phosphate retention → inhibits 1,25-dihydroxyvitamin D production - Uremia → toxic effects on osteoblasts - Acidosis → bone buffering 3. **Result:** Bone is remodeled rapidly but poorly mineralized → paradoxically low BMD on DEXA despite histologically high turnover **Clinical Pearl:** DEXA underestimates fracture risk in renal osteodystrophy because it measures mineral density, not bone quality or turnover. Bone biopsy with tetracycline labeling is the gold standard for diagnosis but rarely done clinically. ## Management Approach - **Phosphate binders** (calcium-free or non-calcium: sevelamer, lanthanum) - **Vitamin D analogs** (calcitriol, paricalcitol) to suppress PTH - **Calcimimetics** (cinacalcet) if PTH remains uncontrolled - **Avoid bisphosphonates** — contraindicated in high-turnover disease **Warning:** Do NOT use bisphosphonates in secondary hyperparathyroidism; they suppress bone turnover further and worsen mineralization defects. ![Osteoporosis diagram](https://mmcphlazjonnzmdysowq.supabase.co/storage/v1/object/public/blog-images/explanation/29867.webp)

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More Orthopedics Questions